Business strategy

Synome capitalises on the extensive experience of its scientists in studying the genetic and physiological basis of brain diseases.

With a unique portfolio of tools to study the impact of mutations on brain function, Synome has the capacity to discover new drug targets and identify their therapeutic application in a wide variety of brain diseases.

Actively collaborating with academic and commercial partners, Synome conducts contract research and also pursues development of its own portfolio of drug candidates.

Synome is positioned to rapidly exploit the new discoveries in medical genetics and convert these into therapeutic advances.